Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 89901-89950 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04772300
Trial to Assess the Safety and Efficacy of Sirolimus-Coated Balloon vs. Uncoated Standard Angioplasty for the Treatment of Below-the-knee Peripheral Arterial Disease
NARecruiting
230 participants
Started: Feb 10, 2022 · Completed: Sep 30, 2028
1 condition5 sponsors23 locations
NCT06956170
All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma
PHASE3Active, not recruiting
21 participants
Started: Feb 10, 2022 · Completed: Nov 30, 2029
1 condition1 sponsor13 locations
NCT05180734
PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer
PHASE3Active, not recruiting
878 participants
Started: Feb 10, 2022 · Completed: Jul 31, 2028
1 condition1 sponsor71 locations
NCT05015504
Application of Time Restriction Feeding in Patients With Type 2 Diabetes Mellitus
NAActive, not recruiting
30 participants
Started: Feb 10, 2022 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05218226
Avatrombopag for Chemotherapy-induced Thrombocytopenia
PHASE2Recruiting
50 participants
Started: Feb 10, 2022 · Completed: Dec 31, 2025
2 conditions7 sponsors1 location
NCT05643079
Medial Displacement Calcaneal Osteotomy and FDL- Transfer - With a Human, Allogeneic Cortical Bone Screw
N/ARecruiting
40 participants
Started: Feb 10, 2022 · Completed: Feb 29, 2028
4 conditions1 sponsor1 location
NCT05062707
Early Ageing During Therapy in AYA Cancer Patients
N/ARecruiting
120 participants
Started: Feb 10, 2022 · Completed: Jul 31, 2025
8 conditions2 sponsors1 location
NCT05125029
Botulinum Toxin in Raynaud's Phenomenon
PHASE4Recruiting
36 participants
Started: Feb 10, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04779320
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
PHASE3Recruiting
120 participants
Started: Feb 10, 2022 · Completed: May 22, 2026
1 condition1 sponsor96 locations
NCT04661280
Donepezil Versus Non-drug Treatment in Alzheimer's Disease.
PHASE3Recruiting
240 participants
Started: Feb 10, 2022 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT06273748
RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
N/ARecruiting
290 participants
Started: Feb 10, 2022 · Completed: May 2, 2032
1 condition1 sponsor5 locations
NCT05292313
Dual Implant Versus Single Implant Distal End of Femur
NAEnrolling by invitation
80 participants
Started: Feb 10, 2022 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT05319678
Analysis of Musical and Voice Skills in Children and Adult Cochlear Implant Users
N/ARecruiting
80 participants
Started: Feb 10, 2022 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT05136664
Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects
PHASE3Recruiting
290 participants
Started: Feb 10, 2022 · Completed: Nov 30, 2025
2 conditions2 sponsors29 locations
NCT05228951
Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC
PHASE2Recruiting
12 participants
Started: Feb 10, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT04542148
Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes
PHASE2Recruiting
120 participants
Started: Feb 10, 2022 · Completed: Mar 31, 2026
4 conditions1 sponsor4 locations
NCT06240468
Dynamic Changes in Human Microbiome Predict the Risk of Adverse Outcomes in Patients With Acute Ischemic Stroke: a Multicenter Prospective Cohort Study
N/ARecruiting
2,000 participants
Started: Feb 10, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05669508
Wearable Electrical Stimulation on the Back to Modulate Spinal Cord Activity
NAActive, not recruiting
4 participants
Started: Feb 10, 2022 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT05105308
Chompions! A Treatment Study for Childhood Avoidant/Restrictive Food Intake Disorder (ARFID)
NAActive, not recruiting
203 participants
Started: Feb 10, 2022 · Completed: Nov 19, 2025
3 conditions2 sponsors1 location
NCT04849884
To Evaluate the Performance of the CORI™ KNEE TENSIONER as an Accessory to the CORI™ Surgical System.
NAActive, not recruiting
50 participants
Started: Feb 10, 2022 · Completed: Apr 30, 2026
3 conditions1 sponsor4 locations
NCT05228041
BIOlogics in Severe Nasal POlyposis SurvEy
N/ARecruiting
100 participants
Started: Feb 10, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT05323201
Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer
PHASE1/PHASE2Recruiting
15 participants
Started: Feb 10, 2022 · Completed: Feb 10, 2027
1 condition3 sponsors1 location
NCT05769699
Serum Biomarkers in Parkinson's Disease at Different Stages
NARecruiting
200 participants
Started: Feb 10, 2022 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT05233722
mTOR as Mediator of Insulin Sensitivity Study
NARecruiting
10 participants
Started: Feb 10, 2022 · Completed: Jun 30, 2029
1 condition2 sponsors1 location
NCT05193721
A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant Tumors
PHASE1Active, not recruiting
25 participants
Started: Feb 10, 2022 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT05208905
LIFE-BTK PK Sub-study
NAActive, not recruiting
9 participants
Started: Feb 10, 2022 · Completed: Feb 22, 2028
1 condition1 sponsor5 locations
NCT05091684
Administration of Fibrinogen Concentrate for Refractory Bleeding
PHASE2Recruiting
10 participants
Started: Feb 10, 2022 · Completed: Mar 31, 2026
3 conditions2 sponsors1 location
NCT06479018
Deciphering IL-17-dependant Inflammatory Response in Bullous Pemphigoid
NARecruiting
140 participants
Started: Feb 10, 2022 · Completed: Jan 10, 2026
1 condition1 sponsor1 location
NCT05263219
DEB-TACE+HAIC vs. HAIC for Large HCC
PHASE3Recruiting
230 participants
Started: Feb 10, 2022 · Completed: Feb 9, 2026
1 condition8 sponsors1 location
NCT06764498
Retrospective Study to Evaluate the Effectiveness of the Approach to Enuresis in Our Center
N/AActive, not recruiting
200 participants
Started: Feb 10, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04817241
Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients
PHASE1/PHASE2Active, not recruiting
55 participants
Started: Feb 10, 2022 · Completed: Oct 25, 2025
1 condition1 sponsor7 locations
NCT05007483
Efficacy of Diet on Quality of Life in Multiple Sclerosis
NAActive, not recruiting
162 participants
Started: Feb 10, 2022 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT06094257
Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients
N/ARecruiting
400 participants
Started: Feb 9, 2022 · Completed: Mar 31, 2033
9 conditions2 sponsors2 locations
NCT04862221
TReatment for ImmUne Mediated PathopHysiology
PHASE2Recruiting
163 participants
Started: Feb 9, 2022 · Completed: May 31, 2027
5 conditions2 sponsors23 locations
NCT05080673
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NARecruiting
9,500 participants
Started: Feb 9, 2022 · Completed: Nov 1, 2065
2 conditions2 sponsors466 locations
NCT05302648
To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects with R/R MM
EARLY_PHASE1Active, not recruiting
18 participants
Started: Feb 9, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05280366
STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma
NAActive, not recruiting
150 participants
Started: Feb 9, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor20 locations
NCT05268887
High Frequency Light, Sound, and Tactile Stimulation to Improve Motor and Cognitive Deficits in Parkinson's Disease
NARecruiting
40 participants
Started: Feb 9, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT04905810
Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure
PHASE2Recruiting
20 participants
Started: Feb 9, 2022 · Completed: Dec 1, 2025
2 conditions3 sponsors4 locations
NCT05329480
Cardiac and Vascular Responses to Creatine Supplementation in Elderly Men
NARecruiting
45 participants
Started: Feb 9, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05176197
Effects of Almonds on Glycemia in Adults With Elevated Hemoglobin A1c Concentrations
NAActive, not recruiting
84 participants
Started: Feb 9, 2022 · Completed: May 30, 2024
2 conditions2 sponsors1 location
NCT05230225
Electronic Physician Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: The DETECT AS Trial
NARecruiting
940 participants
Started: Feb 9, 2022 · Completed: Feb 15, 2026
1 condition2 sponsors1 location
NCT04564976
Social Support and Reduced Fear Acquisition
NARecruiting
100 participants
Started: Feb 9, 2022 · Completed: Jan 31, 2026
2 conditions2 sponsors1 location
NCT04527419
SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)
NARecruiting
545 participants
Started: Feb 9, 2022 · Completed: Feb 9, 2027
1 condition1 sponsor1 location
NCT05038839
Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors
PHASE1Active, not recruiting
44 participants
Started: Feb 9, 2022 · Completed: Jun 3, 2026
2 conditions1 sponsor1 location
NCT04807816
Targeting ATR in Soft-tissue Sarcomas
PHASE2Recruiting
72 participants
Started: Feb 9, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors6 locations
NCT03786003
ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)
NARecruiting
1,086 participants
Started: Feb 9, 2022 · Completed: Feb 9, 2028
1 condition1 sponsor1 location
NCT06591390
Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA
PHASE3Recruiting
900 participants
Started: Feb 9, 2022 · Completed: Oct 1, 2024
1 condition1 sponsor1 location
NCT06008847
Capsule Endoscopy Delivery at sCale Through Enhanced AI anaLysis Study
N/ARecruiting
674 participants
Started: Feb 9, 2022 · Completed: Jan 31, 2025
1 condition2 sponsors1 location
NCT05104775
A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy
PHASE1Active, not recruiting
33 participants
Started: Feb 9, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors7 locations